Targeting tumor-specific inflammatory processes in colorectal cancer could enhance the efficacy of some anticancer therapies and prevent drug resistance, Weill Cornell researchers have found.
Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most of their weight loss, a clinical trial involving Weill Cornell Medicine has found.
While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and the University of Texas at Austin.